Skip to NavigationSkip to content

Pharmafile - Research and Development

To find out more, check out this week’s Top 10 most popular articles on Pharmafile.com now!
Shares in the Texas based biotech Molecular Templates have soared after the company announced that they would be collaborating with Japanese pharma...
Astellas has revealed new Phase 3 data for roxadustat in the treatment of chronic kidney disease (CKD) in patients with anaemia not on dialysis,...
Almirall has announced that the European Commission has approved its interleukin-23 (IL-23) inhibitor Ilumetri (tildrakizumab) for the treatment of...

Features

Dr Rachelle Doody, Global Head of Neurodegeneration at Roche/Genentech, discusses key learnings from clinical trials in Alzheimer’s disease, and...

Appointments

OxStem, a regenerative drug discovery unit spun out from the University of Oxford, has brought on board ex-GlaxoSmithKline R&D exec Georg...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches